Serum erythropoietin and outcome after ischaemic stroke: a prospective study

OBJECTIVES: Erythropoietin (EPO), which is inversely associated with blood haemoglobin (Hb), exerts neuroprotective effects in experimental ischaemic stroke (IS). However, clinical treatment trials have so far been negative. Here, in patients with IS, we analysed whether serum EPO is associated with...

Descripción completa

Detalles Bibliográficos
Autores principales: Åberg, N David, Stanne, Tara M, Jood, Katarina, Schiöler, Linus, Blomstrand, Christian, Andreasson, Ulf, Blennow, Kaj, Zetterberg, Henrik, Isgaard, Jörgen, Jern, Christina, Svensson, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2016
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769431/
https://www.ncbi.nlm.nih.gov/pubmed/26916692
http://dx.doi.org/10.1136/bmjopen-2015-009827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769431/
https://www.ncbi.nlm.nih.gov/pubmed/26916692
http://dx.doi.org/10.1136/bmjopen-2015-009827

Ejemplares similares